Silence Therapeutics Plc (SLNCF)
2.63
+0.27
(+11.44%)
USD |
OTCM |
May 07, 16:00
Silence Therapeutics Research and Development Expense (Annual) : 60.29M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Adaptimmune Therapeutics Plc | 160.54M |
| Biodexa Pharmaceuticals Plc | 5.026M |
| Oxford Biomedica Plc | 82.72M |
| NuCana Plc | 16.79M |
| Autolus Therapeutics Plc | 128.59M |